Target intelligence / Profile preview

RNA, U4 small nuclear 60, pseudogene (RNU4-60P)

Target
RNU4-60P
Molecular classification
Non-coding RNA, Pseudogene, Small nuclear RNA (snRNA)-related
01

Overview

RNA, U4 small nuclear 60, pseudogene (RNU4-60P) is annotated as a pseudogene presumed to be related to U4 small nuclear RNA (snRNA) gene family, which produces structural RNAs critical for pre-mRNA splicing as part of the spliceosome in humans. However, pseudogenes are generally defined as genomic DNA sequences similar to normal genes but non-functional; they are usually not transcribed or translated into functional products. RNU4-60P lacks evidence of encoding a functional RNA molecule, and no data indicate biological activity, disease association, or a role as a therapeutic target. This distinguishes RNU4-60P from functional homologues like RNU4-2, which is essential for major spliceosome assembly and human neurodevelopment[1][2][3][5]. No evidence indicates that RNU4-60P serves as a therapeutic target, biomarker, or is the subject of drug development. ### Notes - The "RNU4-60P" gene is a **pseudogene**, not an active target molecule. Functional disease associations, biological activities, or pharmacological targeting as described for RNU4-2 do **not apply** to pseudogenes unless otherwise shown by experimental evidence (not found for RNU4-60P in the search results). - There are other U4 snRNA genes (e.g., "RNU4-2") with clear roles in splicing and disease[1][2][3][5], but RNU4-60P is not one of them and should not be confused as a functional target. - The query likely refers to a **non-protein-coding pseudogene**, not a druggable or biologically active entity. **In summary: RNU4-60P is a pseudogene (inactive copy) related to U4 snRNA, not a functional therapeutic target, and contains no reported biological function, disease role, or drug interaction.**

Other names
RNU4-60P

Beyond the preview

Go deeper on RNA, U4 small nuclear 60, pseudogene (RNU4-60P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U4 small nuclear 60, pseudogene (RNU4-60P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call